top of page

BSGCT Services to the Society Award 2024

Professor Simon Waddington

The BSGCT board considered that Prof Simon Waddington’s dedication to helping the society’s outreach and engagement goals is outstanding. He has supported BSGCT from its inception and has selflessly given his time to present at the annual Public Engagement Day or whenever he was asked. Simon’s interest and efforts in the training and promotion of early career researchers, supporting them all the way to senior posts are equally commendable.

Simon Waddington is Professor of Gene Therapy at UCL. He leads a team developing translational gene therapy for childhood inherited genetic diseases including neurodegenerative diseases, inherited epilepsy and metabolic diseases. He and his team have more than one hundred and sixty peer reviewed publications in journals including Nature, Cell, Nature Medicine, Science Translational Medicine, Nature Immunology, Nature Communications, Cell Metabolism and Blood.

With Professors Manju Kurian, Paul Gissen and Ahad Rahim, he has co-founded a gene therapy company “Bloomsbury Genetic Therapies” to progress four gene therapy programmes to the clinic, namely Ornithine Transcarbamylase Deficiency, Infantile Neuronaxonal Dystrophy, Niemann Pick C and Dopamine Transporter Deficiency Syndrome. Simon served on the board of BSGCT between 2007 and 2010.


Commenting has been turned off.
bottom of page